ArticlePloS one2016

Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist.

Aaron S Coyner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.